trending Market Intelligence /marketintelligence/en/news-insights/trending/JDi5cVD1uQmSHiBagZqbdQ2 content esgSubNav
In This List

EyeGate prices $10M common stock, warrants offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

EyeGate prices $10M common stock, warrants offering

Eyegate Pharmaceuticals Inc. is looking to raise $10 million via a public offering.

The company will issue 6,666,667 shares at $1.50 apiece, complete with warrants to purchase an additional 6,666,667 stock within five years from the date of issue at the same price.

EyeGate plans to use the net proceeds for clinical trials, working capital and general corporate purposes.

Rodman & Renshaw is acting as the exclusive placement agent for the offering which is expected to close by June 14.